Failure of Pentoxifylline for End-stage Peripheral Vascular Disease

Loyd, Robert G.; Prian, Gregory W.; Gomez, Henry; Laub, James; Mertz, George H.
April 1987
Angiology;Apr1987, Vol. 38 Issue 4, p304
Academic Journal
In this trial of pentoxifylline, 15 patients with end-stage peripheral vascular disease had symptoms severe enough to warrant operation, but surgery was contraindicated because of anatomically noncorrectable disease, serious medical problems, or refusal. Their mean age was sixty-six years. Each patient received oral pentoxifylline, 400 mg tid, for twelve weeks. Pentoxifylline had no measurable clinical benefit in 14 of the patients. In addition, the authors noted an increased incidence of symptomatic coronary artery insufficiency during the trial period that may or may not have been drug related.


Related Articles

  • Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication? Weismantel, David // Journal of Family Practice;Feb2001, Vol. 50 Issue 2, p181 

    This article presents a study which examined the effectiveness of cilostazol over pentoxifylline in the treatment of symptoms of intermittent claudication. The study population is composed of patients with stable moderate to severe symptoms of intermittent claudication and confirmed peripheral...

  • pentoxifylline.  // Royal Society of Medicine: Medicines;2002, p431 

    This article presents information on pentoxifylline, a vasodilator drug which dilates the blood vessels of the extremities and can be used to treat peripheral vascular disease such as Raynaud's phenomenon. Administration is oral. Side effects include gastrointestinal disturbances, agitation and...

  • Continuous Infusion Treatment with Pentoxifylline in Patients with Severe Peripheral Vascular Occlusive Disease. Angelides, N. S. // Angiology;Aug1986, Vol. 37 Issue 8, p555 

    The effect of continuous i.v. infusion of pentoxifylline, administering 1 200 mg/24 hours through 15 days, was studied in 22 patients (19 m, 3 f) with arterio-graphically confirmed extensive occlusion in the femoro-popIiteal segment, associated with marked intermittent claudication and rest pain...

  • Studies on the Mechanisms Responsible for Inhibition of Experimental Metastasis of B16-F10 Murine Melanoma by Pentoxifylline. Gude, Rajiv P.; Binda, M. Mercedes; Presas, Hector L�pez; Klein-Szanto, Andr�s J.P.; Bonfil, R. Daniel // Journal of Biomedical Science;1999, Vol. 6 Issue 2, p133 

    Pentoxifylline (PTX), a methylxanthine derivative widely used as a hemorheological agent in the treatment of peripheral vascular disease, was studied to unveil the mechanisms responsible for its inhibitory action on B16-F10 experimental metastasis. In vitro pretreatment of B16-F10 cells with...

  • pentoxifylline.  // Davis's Drug Guide for Nurses, 10th edition;2007, p940 

    The article presents information on the drug pentoxifylline for nurses. This is a blood viscosity reducing agent used for management of symptomatic peripheral vascular disease. By inhibiting platelet aggregation and decreasing fibrinogen, the drug decreases blood viscosity. Pentoxifylline is...

  • Pentoxifylline in the Treatment of Vascular Impotence--Case Reports. Allenby, Kent S.; Burris, James F.; Mroczek, William J. // Angiology;May1991, Vol. 42 Issue 5, p418 

    Vascular impotence is a common medical problem for which available therapies are limited. Three impotent patients observed in the authors' practice who were receiving pentoxifylline for treatment of claudication of the lower extremities spontaneously reported improved sexual function. A...

  • Synthesis and rheological activity of new 1,2,4-triazole derivatives. Klen, E.; Khaliullin, F.; Spasov, A.; Makarova, N.; Bagautdinova, L.; Naumenko, L. // Pharmaceutical Chemistry Journal;Sep2008, Vol. 42 Issue 9, p510 

    Reactions of 3,5-dibromo-1,2,4-triazoles containing thietane or thietane-1,1-dioxide with thioglycolic acid yielded 2-[1-(thietanyl-3)-or 2-[1-(1,1-dioxothietanyl-3)-3-bromo-1,2,4-triazolyl-5-thio]acetic acids. Their salts have also been synthesized via reactions with amines and alkalis....

  • Preventive Effect of Pentoxifylline on Acute Radiation Damage via Antioxidant and Anti-inflammatory Pathways. Hepgül, Gülçin; Tanrıkulu, Sevda; Ünalp, Haluk Recai; Akguner, Taner; Erbil, Yeşim; Olgaç, Vakur; Ademoğlu, Evin // Digestive Diseases & Sciences;Mar2010, Vol. 55 Issue 3, p617 

    Purpose The aim of the present study was to investigate whether pentoxifylline (PTX) treatment could protect against induced acute radiation enteritis. Method Rats received 100 mg/kg/day PTX for 7 days before irradiation and continued on treatment for 3 days after irradiation. The intestinal...

  • Pentoxifylline Treatment in Patients with Occlusive Peripheral Arterial Disease. Circulatory Changes and Effects on Prostaglandin Synthesis. Poggesi, Loredana; Scarti, Luca; Boddi, Maria; Masolti, Giulio; Neri Serneri, Gian Gastone // Angiology;Sep1985, Vol. 36 Issue 9, p628 

    Pentoxifylline has recently been reported to stimulate in vitro the synthesis of prostacyclin. However it is not known so far whether the drug is able to stimulate prostacyclin synthesis in man also in vivo. In the present study the effects of pentoxifylline on prostaglandin synthesis and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics